EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Long-Term Results of the Birmingham Hip Resurfacing Implant in the United States

William A Zuke, Charles P Hannon iD, Rondek Salih iD, Joseph Kromka, Caroline Granger, John C Clohisy, Robert L Barrack iD

Journal of Bone and Joint Surgery · 2025

DOI: 10.2106/jbjs.24.00926 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bone and Joint Surgery, 2025. Verfasst von William A Zuke und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Washington University in St. Louis, St. Louis, Missouri. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Hip Prosthesis, Osteoarthritis, Hip. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We previously reported the 5-year results of the Birmingham Hip Resurfacing (BHR) implant. This study evaluates BHR survivorship as well as radiographic and clinical outcomes at long-term follow-up.

Methods

A total of 224 patients with contemporary indications, including 179 patients from the original study, were included in this analysis. Survivorship was calculated. Metal ion levels and radiographs were updated. Patient-reported outcomes (PROs) were compared with those for matched patients who had undergone total hip arthroplasty (THA). The mean follow-up was 14 years.

Results

Survivorship free from any revision and from aseptic revision was 96.0% and 97.4% at 15 years, respectively. Two patients had undergone revision since the original study. The median serum cobalt and chromium levels were 1.4 and 1.5 ppb, respectively. The PROs were similar to those for the THA cohort. Equal proportions of patients remained active; however, the BHR group trended toward more remaining highly active (p = 0.12).

Conclusions

Although activity was similar to THA at long-term follow-up, the BHR implant remains an excellent option for the treatment of osteoarthritis in younger male patients. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthroplasty, Replacement, HipHip ProsthesisOsteoarthritis, HipHumansMaleFemaleMiddle AgedAdultProsthesis DesignUnited StatesPatient Reported Outcome MeasuresAgedReoperationProsthesis FailureFollow-Up StudiesTreatment OutcomeCobaltRetrospective StudiesChromium

Substanzen

CobaltChromium

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Washington University in St. Louis, St. Louis, Missouri.
  • Department of Orthopaedic Surgery, Mayo Clinic, Rochester, Minnesota.

ORCID-Profile: Charles P Hannon, Rondek Salih, Robert L Barrack

Zitieren

APA

Zuke, W. A., Hannon, C. P., Salih, R., Kromka, J., Granger, C., Clohisy, J. C., & Barrack, R. L. (2025). Long-Term Results of the Birmingham Hip Resurfacing Implant in the United States. Journal of Bone and Joint Surgery. https://doi.org/10.2106/jbjs.24.00926

Vancouver

Zuke WA, Hannon CP, Salih R, Kromka J, Granger C, Clohisy JC, et al. Long-Term Results of the Birmingham Hip Resurfacing Implant in the United States. Journal of Bone and Joint Surgery. 2025. doi:10.2106/jbjs.24.00926

BibTeX
@article{Zuke2025,
  author = {Zuke, William A and Hannon, Charles P and Salih, Rondek and Kromka, Joseph and Granger, Caroline and Clohisy, John C and Barrack, Robert L},
  title = {Long-Term Results of the Birmingham Hip Resurfacing Implant in the United States},
  journal = {Journal of Bone and Joint Surgery},
  year = {2025},
  doi = {10.2106/jbjs.24.00926}
}
Kostenlos starten →